Coya Therapeutics (COYA) Total Current Liabilities (2021 - 2026)

Coya Therapeutics (COYA) has 6 years of Total Current Liabilities data on file, last reported at $3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 18.3% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 18.3% YoY), and the FY2025 full-year result was $5.9 million, up 53.53% from the prior year.
• Total Current Liabilities declined to $3.5 million in Q1 2026, from $5.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $5.9 million in Q4 2025 to a low of $1.2 million in Q2 2023.
• A 5-year average of $3.5 million and a median of $3.8 million in 2022 frame the typical range for Total Current Liabilities.
• Peak annual rise in Total Current Liabilities reached 241.05% in 2024, while the deepest fall reached 24.3% in 2024.
• Tracing COYA's Total Current Liabilities over 5 years: stood at $3.8 million in 2022, then jumped by 32.13% to $5.1 million in 2023, then declined by 24.3% to $3.8 million in 2024, then surged by 53.53% to $5.9 million in 2025, then tumbled by 39.6% to $3.5 million in 2026.
• Business Quant data shows COYA's Total Current Liabilities at $3.5 million in Q1 2026, $5.9 million in Q4 2025, and $3.7 million in Q3 2025.